Severe respiratory syncytial virus infection in older adults – burden, clinical outcomes and implications for care
- 6 May 2025
- journal article
- Published by Elsevier in Respiratory Medicine and Research
- Vol. 88, 101173
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto
- Foundation for Science and Technology (UI/BD/150742/2020)
- Universidade do Porto
- Fundação Bial
This publication has 23 references indexed in Scilit:
- Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virusVaccine, 2024
- RSV vaccination strategies for high-risk patients 2023: a collaborative position paper by leading German medical societies and organizationsInfection, 2023
- Comparative analysis of RSV-related hospitalisations in children and adults over a 7 year-period before, during and after the COVID-19 pandemicJournal of Clinical Virology, 2023
- Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter StudyClinical Infectious Diseases, 2023
- Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscapeThe Lancet Infectious Diseases, 2022
- Perceptions of the safety of vaccines and vaccine associated knowledge levels in Europe: A 2019 cross-sectional study in 28 countriesPreventive Medicine, 2022
- Severity of RSV infection in Southern European elderly patients during two consecutive winter seasons (2017–2018)Journal of Medical Virology, 2021
- Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus InfectionThe Journal of Infectious Diseases, 2020
- Respiratory Syncytial Virus–Associated Hospitalizations Among Adults With Chronic Medical ConditionsClinical Infectious Diseases, 2020
- Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older AdultsClinical Infectious Diseases, 2018